Skip to main content
Erschienen in: European Spine Journal 1/2017

18.10.2016 | Letter to the Editor

Letter to the Editor concerning “Surgical treatment of sacral chordoma: survival and prognostic factors” by C. Ruosi et al. (Eur Spine J; 2015; 24(Suppl 7):S912–S917

verfasst von: Ming-Xiang Zou, Guo-Hua Lv, Xiao-Bin Wang, Jing Li

Erschienen in: European Spine Journal | Ausgabe 1/2017

Einloggen, um Zugang zu erhalten

Excerpt

Dear Editor, …
Literatur
1.
Zurück zum Zitat Ruosi C, Colella G, Di Donato SL, Granata F, Di Salvatore MG, Fazioli F (2015) Surgical treatment of sacral chordoma: survival and prognostic factors. Eur Spine J 24(Suppl 7):912–917CrossRefPubMed Ruosi C, Colella G, Di Donato SL, Granata F, Di Salvatore MG, Fazioli F (2015) Surgical treatment of sacral chordoma: survival and prognostic factors. Eur Spine J 24(Suppl 7):912–917CrossRefPubMed
2.
Zurück zum Zitat Hayden JA, Côté P, Bombardier C (2006) Evaluation of the quality of prognosis studies in systematic reviews. Ann Intern Med 144(6):427–437CrossRefPubMed Hayden JA, Côté P, Bombardier C (2006) Evaluation of the quality of prognosis studies in systematic reviews. Ann Intern Med 144(6):427–437CrossRefPubMed
3.
Zurück zum Zitat Bentzen SM (2001) Prognostic factor studies in oncology: osteosarcoma as a clinical example. Int J Radiat Oncol Biol Phys 49(2):513–518CrossRefPubMed Bentzen SM (2001) Prognostic factor studies in oncology: osteosarcoma as a clinical example. Int J Radiat Oncol Biol Phys 49(2):513–518CrossRefPubMed
4.
Zurück zum Zitat Kayani B, Sewell MD, Tan KA, Hanna SA, Williams R, Pollock R, Skinner J, Briggs TW (2015) Prognostic factors in the operative management of sacral chordomas. World Neurosurg 84(5):1354–1361CrossRefPubMed Kayani B, Sewell MD, Tan KA, Hanna SA, Williams R, Pollock R, Skinner J, Briggs TW (2015) Prognostic factors in the operative management of sacral chordomas. World Neurosurg 84(5):1354–1361CrossRefPubMed
5.
Zurück zum Zitat Kayani B, Hanna SA, Sewell MD, Saifuddin A, Molloy S, Briggs TW (2014) A review of the surgical management of sacral chordoma. Eur J Surg Oncol 40(11):1412–1420CrossRefPubMed Kayani B, Hanna SA, Sewell MD, Saifuddin A, Molloy S, Briggs TW (2014) A review of the surgical management of sacral chordoma. Eur J Surg Oncol 40(11):1412–1420CrossRefPubMed
6.
Zurück zum Zitat Smith DL, Soria JC, Morat L, Yang Q, Sabatier L, Liu DD, Nemr RA, Rashid A, Vauthey JN (2004) Human telomerase reverse transcriptase (hTERT) and Ki-67 are better predictors of survival than established clinical indicators in patients undergoing curative hepatic resection for colorectal metastases. Ann Surg Oncol 11:45–51CrossRefPubMed Smith DL, Soria JC, Morat L, Yang Q, Sabatier L, Liu DD, Nemr RA, Rashid A, Vauthey JN (2004) Human telomerase reverse transcriptase (hTERT) and Ki-67 are better predictors of survival than established clinical indicators in patients undergoing curative hepatic resection for colorectal metastases. Ann Surg Oncol 11:45–51CrossRefPubMed
7.
Zurück zum Zitat González-Sistal A, Sánchez AB, Del Rio MC, Arias JI, Herranz M, Ruibal A (2014) Association between tumor size and immunohistochemical expression of Ki-67, p53 and BCL2 in a node-negative breast cancer population selected from a breast cancer screening program. Anticancer Res 34(1):269–273PubMed González-Sistal A, Sánchez AB, Del Rio MC, Arias JI, Herranz M, Ruibal A (2014) Association between tumor size and immunohistochemical expression of Ki-67, p53 and BCL2 in a node-negative breast cancer population selected from a breast cancer screening program. Anticancer Res 34(1):269–273PubMed
8.
Zurück zum Zitat Zou MX, Lv GH, Li J, She XL, Jiang Y (2016) Upregulated human telomerase reverse transcriptase (hTERT) expression is associated with spinal chordoma growth, invasion and poor prognosis. Am J Transl Res 8(2):516–529PubMedPubMedCentral Zou MX, Lv GH, Li J, She XL, Jiang Y (2016) Upregulated human telomerase reverse transcriptase (hTERT) expression is associated with spinal chordoma growth, invasion and poor prognosis. Am J Transl Res 8(2):516–529PubMedPubMedCentral
9.
Zurück zum Zitat von Witzleben A, Goerttler LT, Lennerz J, Weissinger S, Kornmann M, Mayer-Steinacker R, von Baer A, Schultheiss M, Möller P, Barth TF (2015) In chordoma, metastasis, recurrences, Ki-67 index, and a matrix-poor phenotype are associated with patients’ shorter overall survival. Eur Spine J. doi:10.1007/s00586-015-4242-1 von Witzleben A, Goerttler LT, Lennerz J, Weissinger S, Kornmann M, Mayer-Steinacker R, von Baer A, Schultheiss M, Möller P, Barth TF (2015) In chordoma, metastasis, recurrences, Ki-67 index, and a matrix-poor phenotype are associated with patients’ shorter overall survival. Eur Spine J. doi:10.​1007/​s00586-015-4242-1
10.
Zurück zum Zitat Angelini A, Pala E, Calabrò T, Maraldi M, Ruggieri P (2015) Prognostic factors in surgical resection of sacral chordoma. J Surg Oncol 112:344–351CrossRefPubMed Angelini A, Pala E, Calabrò T, Maraldi M, Ruggieri P (2015) Prognostic factors in surgical resection of sacral chordoma. J Surg Oncol 112:344–351CrossRefPubMed
11.
Zurück zum Zitat Stacchiotti S, Casali PG, Lo Vullo S, Mariani L, Palassini E, Mercuri M, Alberghini M, Pilotti S, Zanella L, Gronchi A, Picci P (2010) Chordoma of the mobile spine and sacrum: a retrospective analysis of a series of patients surgically treated at two referral centers. Ann Surg Oncol 17:211–219CrossRefPubMed Stacchiotti S, Casali PG, Lo Vullo S, Mariani L, Palassini E, Mercuri M, Alberghini M, Pilotti S, Zanella L, Gronchi A, Picci P (2010) Chordoma of the mobile spine and sacrum: a retrospective analysis of a series of patients surgically treated at two referral centers. Ann Surg Oncol 17:211–219CrossRefPubMed
12.
Zurück zum Zitat Varga PP, Szövérfi Z, Fisher CG, Boriani S, Gokaslan ZL, Dekutoski MB, Chou D, Quraishi NA, Reynolds JJ, Luzzati A, Williams R, Fehlings MG, Germscheid NM, Lazary A, Rhines LD (2015) Surgical treatment of sacral chordoma: prognostic variables for local recurrence and overall survival. Eur Spine J 24:1092–1101CrossRefPubMed Varga PP, Szövérfi Z, Fisher CG, Boriani S, Gokaslan ZL, Dekutoski MB, Chou D, Quraishi NA, Reynolds JJ, Luzzati A, Williams R, Fehlings MG, Germscheid NM, Lazary A, Rhines LD (2015) Surgical treatment of sacral chordoma: prognostic variables for local recurrence and overall survival. Eur Spine J 24:1092–1101CrossRefPubMed
13.
Zurück zum Zitat Radaelli S, Stacchiotti S, Ruggieri P, Donati D, Casali PG, Palmerini E, Collini P, Gambarotti M, Porcu L, Boriani S, Gronchi A, Picci P (2016) Sacral chordoma: long-term outcome of a large series of patients surgically treated at two reference centers. Spine (Phila Pa 1976) 41:1049–1057CrossRef Radaelli S, Stacchiotti S, Ruggieri P, Donati D, Casali PG, Palmerini E, Collini P, Gambarotti M, Porcu L, Boriani S, Gronchi A, Picci P (2016) Sacral chordoma: long-term outcome of a large series of patients surgically treated at two reference centers. Spine (Phila Pa 1976) 41:1049–1057CrossRef
14.
Zurück zum Zitat Zou MX, Huang W, Wang XB, Li J, Lv GH, Wang B, Deng YW (2015) Reduced expression of miRNA-1237-3p associated with poor survival of spinal chordoma patients. Eur Spine J 24:1738–1746CrossRefPubMed Zou MX, Huang W, Wang XB, Li J, Lv GH, Wang B, Deng YW (2015) Reduced expression of miRNA-1237-3p associated with poor survival of spinal chordoma patients. Eur Spine J 24:1738–1746CrossRefPubMed
15.
Zurück zum Zitat Chen H, Zhang K, Wu G, Song D, Chen K, Yang H (2015) Low expression of PHLPP1 in sacral chordoma and its association with poor prognosis. Int J Clin Exp Pathol 8:14741–14748PubMedPubMedCentral Chen H, Zhang K, Wu G, Song D, Chen K, Yang H (2015) Low expression of PHLPP1 in sacral chordoma and its association with poor prognosis. Int J Clin Exp Pathol 8:14741–14748PubMedPubMedCentral
16.
Zurück zum Zitat Zou MX, Huang W, Wang XB, Lv GH, Li J, Deng YW (2014) Identification of miR-140-3p as a marker associated with poor prognosis in spinal chordoma. Int J Clin Exp Pathol 7:4877–4885PubMedPubMedCentral Zou MX, Huang W, Wang XB, Lv GH, Li J, Deng YW (2014) Identification of miR-140-3p as a marker associated with poor prognosis in spinal chordoma. Int J Clin Exp Pathol 7:4877–4885PubMedPubMedCentral
Metadaten
Titel
Letter to the Editor concerning “Surgical treatment of sacral chordoma: survival and prognostic factors” by C. Ruosi et al. (Eur Spine J; 2015; 24(Suppl 7):S912–S917
verfasst von
Ming-Xiang Zou
Guo-Hua Lv
Xiao-Bin Wang
Jing Li
Publikationsdatum
18.10.2016
Verlag
Springer Berlin Heidelberg
Erschienen in
European Spine Journal / Ausgabe 1/2017
Print ISSN: 0940-6719
Elektronische ISSN: 1432-0932
DOI
https://doi.org/10.1007/s00586-016-4819-3

Weitere Artikel der Ausgabe 1/2017

European Spine Journal 1/2017 Zur Ausgabe

Arthropedia

Grundlagenwissen der Arthroskopie und Gelenkchirurgie. Erweitert durch Fallbeispiele, Videos und Abbildungen. 
» Jetzt entdecken

Update Orthopädie und Unfallchirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.